Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease

PHASE4UnknownINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Fatty LiverDyslipidemiasDiabetes Mellitus

Interventions

DRUG

atorvastatin

Oral atorvastatin 20mg, qd, for 24 weeks

DRUG

Vitamin E

Oral Vitamin E 300mg, qd, for 24 weeks

Trial Locations (1)

RECRUITING

Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai